Top Industry News

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eli Lilly and Company, Novartis, Otsuka, SK Biopharmaceuticals, and Stada. Highlights below.    For the latest news roundup on small and Emerging Pharma companies,…

The latest from small and Emerging Pharma companies featuring Campfield Therapeutics, Ollin Biosciences, RQ Bio, Sangamo Therapeutics, Serapha Bio, Boundless Bio, and Vedana Therapeutics.   For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * Campfield…

Johnson & Johnson (J&J) is investing $1 billion in its MedTech business through an expansion of manufacturing, packaging, and distribution capabilities at its facility in Jacksonville, Florida, for its Acuvue contact lenses. The company’s MedTech business focuses on surgical, cardiovascular, orthopedic, and…

Chiesi Group, a Parma, Italy-based bio/pharmaceutical company, has completed its $1.9-billion acquisition of KalVista Pharmaceuticals, a Framingham, Massachusetts-based commercial-stage bio/pharmaceutical company. The companies had announced the acquisition in April (April 2026).   KalVista’s lead product is Ekterly (sebetralstat) for treating hereditary angioedema…

The US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s pharmaceutical regulatory authority, have announced a new liaison program to establish dedicated, reciprocal liaison officer roles…

As part of US drug-pricing reforms, a new proposal from the US Centers for Medicare & Medicaid Services (CMS) would establish a permanent framework for the Medicare Drug Price Negotiation Program by…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eisai, Bayer, Biogen, Eli Lilly and Company, Merck & Co, Moderna and Jazz Pharmaceuticals. Highlights below.   For the latest news roundup on…

The latest from CDMOs, CMOs, and suppliers featuring Neuland Laboratories, TriLink, Recipharm, Catalent and Codis.   Chemicals/Chemical API Manufacturing * Neuland Labs Investing $20 M in Process Development Facility Biologics Manufacturing * TriLink Opens Enzyme Mfg Facility…

The latest from small and Emerging Pharma companies featuring Enliven, Simulations Plus and Kardigan.  For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * Enliven Raises $460 M To Support…

GSK has agreed to acquire Nuvalent, a Boston-based clinical-stage bio/pharmaceutical company focused on oncology therapies, for $10.6 billion.  Nuvalent is developing small molecules that are designed to overcome the limitations of existing therapies for clinically…